FDA Drugs (New Approvals & NDA)Original article
Centaur Pharmaceuticals Private Ltd. - 651080 - 12/03/2025
RegulatoryNegative
AI Analysis
Summary
Centaur Pharmaceuticals Private Ltd. (651080) received a regulatory action from FDA on 12/03/2025 related to CGMP violations and adulterated Active Pharmaceutical Ingredients, indicating serious manufacturing compliance issues.
Outcome Details
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
Importance:6/10
Sentiment:
-0.80
regulatory_actionCGMP_violationAPI_adulterationFDA_enforcement
Related Companies
Read the original article
Published by FDA Drugs (New Approvals & NDA) on July 21, 2026 4:20 PM